Interventions Used With Cholescintigraphy for the Diagnosis of Hepatobiliary Disease

Seminars in Nuclear Medicine

Volumn 39, Issue 3, 2009, Pages 174-185

  Ziessman, Harvey A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ATROPINE; BENZODIAZEPINE; BUPRENORPHINE; BUTORPHANOL; BUTORPHANOL TARTRATE; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; DEXTROMORAMIDE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIGLYCINE TECHNETIUM TC 99M; DISOFENIN; FENTANYL; HYCODON; HYDROCODONE; HYDROXYZINE; LEVORPHANOL; MEBROFENIN; MORPHINE SULFATE; NALBUPHINE; NICOTINE; NIFEDIPINE; NUBAINE; OCTOPAMINE; OCTREOTIDE; OPIATE; OXYCODONE; PENTAZOCINE; PETHIDINE; PHENOPERIDINE; PIRENZEPINE; PROGESTERONE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE CHOLECYSTITIS; BILE DUCT ATRESIA; BILE DUCT OBSTRUCTION; CHOLECYSTECTOMY; CHRONIC CHOLECYSTITIS; DRUG ELIMINATION; DRUG METABOLISM; GALLBLADDER CONTRACTION; GALLBLADDER SCINTISCANNING; HALF LIFE TIME; HEPATOBILIARY DISEASE; HUMAN; INTERVENTIONAL RADIOLOGY; REVIEW;

BILIARY TRACT DISEASES; CHOLECYSTITIS; CHOLECYSTITIS, ACUTE; CHOLECYSTOKININ; CHRONIC DISEASE; GALLBLADDER EMPTYING; HUMANS; MORPHINE; RADIOPHARMACEUTICALS; SINCALIDE; TECHNETIUM TC 99M DIETHYL-IMINODIACETIC ACID;

EID: 63049098319     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2008.12.002     Document Type: Review

References (75)

1. Ziessman H.A., Zeman R.K., and Akin E.A. Cholescintigraphy: Correlation with other hepatobiliary imaging modalities. In: Sandler M.P., Coleman R.E., Patton J.A., et al. (Eds). Diagnostic Nuclear Medicine. 4 (2003), Lippincott Williams & Wilkins, Philadelphia 503-529
2. Freitas J.E., Mirkes S.H., Fink-Bennett D.M., et al. Suspected acute cholecystitis. Comparison of hepatobiliary scintigraphy versus ultrasonography. Clin Nucl Med 8 (1982) 364-367
3. Zeman R.K., Burrell M.I., Cahow C.E., et al. Diagnostic utility of cholescintigraphy and ultrasonography in acute cholecystitis. Am J Surg 141 (1981) 446-451
4. Ziessman H.A. Acute cholecystitis, biliary obstruction, and biliary leakage. Semin Nucl Med 33 (2003) 279-296
5. Weissmann H.S., Badia J., Sugarman L.A., et al. Spectrum of 99mTc-IDA cholescintigraphic patterns in acute cholecystitis. Radiology 138 (1981) 167-175
6. Weissmann H.S., Frank M.S., Bernstein L.H., et al. Rapid and accurate diagnosis of acute cholecystitis with 99m Tc-IDA cholescintigraphy. AJR Am J Roentgenol 132 (1979) 523-528
7. Weissmann H.S., Sugarman L.A., and Freeman L.M. The clinical role of technetium-99m iminodiacetic acid cholescintigraphy. In: Freeman L.M., and Weissmann H.S. (Eds). Nuclear Medicine Annual 1981 (1981), Raven Press, New York 879-1049
8. Choy D., Shi E.C., McLean R.G., et al. Cholescintigraphy in acute cholecystitis: use of intravenous morphine. Radiology 151 (1984) 203-207
9. Fink-Bennett, Balon H., Robbins T., et al. Morphine-augmented cholescintigraphy: Its efficacy in detecting acute cholecystitis. J Nucl Med 32 (1991) 1231-1233
10. Kistler A.M., Ziessman H.A., Gooch D., et al. Morphine augmented cholescintigraphy in acute cholecystitis. A satisfactory alternative to delayed imaging. Clin Nucl Med 16 (1991) 404-406
11. Fig L.M., Wahl R.L., Stewart R.E., et al. Morphine-augmented cholescintigraphy: Its efficacy in detection of acute cholecystitis. J Nucl Med 323 (1991) 1231-1233
12. Krishnamurthy G.T., and Krishnamurthy S. Nuclear Hepatology (2000), Berlin, Springer-Verlag
13. Holbrook R.F., Jacobson F.L., Pezzuti R.T., et al. Biliary patency imaging after endoscopic retrograde sphincterotomy with gallbladder in situ. Clinical impact of nonvisualization. Arch Surg 126 (1991) 738-741
14. Anchong D.M., and Oates E. Normal gallbladder ejection fraction after morphine augmentation. Clin Nucl Med 24 (1999) 837-841
15. Krishnamurty S., and Krishnamurthy G.T. Effect of sequential administration of an opioid and cholecystokinin on gallbladder ejection fraction: Brief communication. J Nucl Med 47 (2006) 1463-1466
16. Ziessman H.A. Cholecystokinin cholescintigraphy: Victim of its own success?. J Nucl Med 40 (1999) 2038-2042
17. Mitsukawa T., Takemura J., Nishizono F., et al. Effects of atropine, proglumide, and somatostatin analogue on bombesin-induced gallbladder contraction and CCK secretion in humans. Am J Gastroenterol 84 (1989) 1371-1374
18. Kubota K., Sugayha K., Sunagane N., et al. Cholecystokinin antagonism by benzodiazepines in the contractile response of the isolated guinea-pig gallbladder. Eur J Pharmacol 110 (1985) 225-231
19. Masui H., Wakabayashi I., Hatake K., et al. Effects of ethanol on contractile response of the gallbladder isolated from guinea pig. Eur J Pharmacol 248 (1993) 103-110
20. Clas D., Hould F.S., Rosenthall L., et al. Nifedipine inhibits cholecystokinin-induced gallbladder contraction. J Surg Res 46 (1989) 479-483
21. Grimaldi C., Darcourt J., Harris A.G., et al. Cholescintigraphic study of effect of somatostatin analog, octreotide, on bile secretion and gallbladder emptying in normal subjects. Dig Dis Sci 38 (1993) 1718-1721
22. Utkan N.Z., Utkan T., Sariouglu Y., et al. Investigation of the mechanism of nicotine-induced relaxation in guinea pig gallbladder. J Surg Res 110 (2003) 272-275
23. Tankurt E., Yegen B.C., Biren T., et al. Influence of pirenzepine on gallbladder contraction in man induced by sham feeding or an intraduodenal meal. Digestion 51 (1992) 103-109
24. Shaffer E.A., Taylor P.J., Logan K., et al. The effect of a progestin on gallbladder function in young women. Am J Obstet Gynecol 148 (1984) 504-507
25. Ishikawa Y., Takahashi T., and Yamamura T. Effect of apamin and theophylline on adenosine-5-triophosphonate-induced response of the guinea pig gallbladder. Digestion 27 (1983) 234-238
26. Caturelli E., Squillante M.M., Fusilli S., et al. Gallbladder emptying in patients with primary achalasia. Digestion 52 (1992) 152-156
27. Brown A.M., Bradshaw M.J., Richardson R., et al. Pathogenesis of the impaired gall bladder contraction of celiac disease. Gut 28 (1987) 1426-1432
28. Murray F.E., McNicholas M., Stack W., et al. Impaired fatty meal-stimulated gallbladder contractility in patients with Crohn's disease. Clin Sci (Lond) 83 (1992) 689-693
29. Shaw S.J., Hajnal F., Lebovitz Y., et al. Gallbladder dysfunction in diabetes mellitus. Dig Dis Sci 38 (1993) 490-496
30. Sood G.K., Baijal S.S., Lahoti D., et al. Abnormal gallbladder function in patients with irritable bowel syndrome. Am J Gastroenterol 88 (1993) 1387-1390
31. Braverman D.Z., Herbert D., Goldstein R., et al. Postpartum restoration of pregnancy-induced cholecystoparesis and prolonged intestinal transit time. J Clin Gastroenterol 10 (1988) 642-646
32. Johna S., Shaul D., Taylor E.W., et al. Laparoscopic management of gallbladder disease in children and adolescents. JSLS 1 (1997) 241-245
33. Masclee A.A.M., Jansen J.B.M.J., Cortsens F.H.M., et al. Reversible gallbladder dysfunction in severe pancreatic insufficiency. Gut 30 (1989) 866-872
34. Weissmann H.S., Berkowitz D., Fox M.S., et al. The role of technetium-99m iminodiacetic acid (IDA) cholescintigraphy in acute acalculous cholecystitis. Radiology 146 (1983) 177-180
35. Prevot N., Mariat G., Mahul P., et al. Contribution of cholescintigraphy to the early diagnosis of acute acalculous cholecystitis in intensive care unit patients. Eur J Nucl Med 26 (1999) 1317-1325
36. Lantto E., Jarvi K., Laitinen R., et al. Scintigraphy with 99m Tc-HMPAO labeled leukocytes in acute cholecystitis. Acta Radiol 32 (1991) 359-362
37. Fink-Bennett D., Clark K., Tsai D., et al. Indium-111 leukocyte imaging in acute cholecystitis. J Nucl Med 32 (1991) 803-804
38. Goldberg H.I. Cholecystokinin cholecystography. Semin Roentgenol 11 (1976) 175-179
39. Dunn F.H., Christensen E.D., Reynolds J., et al. Cholecystokinin cholecystography. Controlled evaluation in the diagnosis and management of patients with possible acalculous gallbladder disease. JAMA 228 (1974) 997-1003
40. Smythe A., Majeed A.W., Fitzhenry M., et al. A requiem for the cholecystokinin provocation test?. Gut 43 (1998) 571-574
41. Krishnamurthy G.T., Bobba V.R., and Kingston E. Radionuclide ejection fraction: A technique for quantitative analysis of motor function of the human gallbladder. Gastroenterology 80 (1981) 482-490
42. Middleton G.W., and Williams J.H. Diagnostic accuracy of 99mTc-HIDA with cholecystokinin and gallbladder ejection fraction in acalculous gallbladder disease. Nucl Med Commun 22 (2001) 657-661
43. Fink-Bennett D., DeRidder P., Kolozsi W.Z., et al. Cholecystokinin cholescintigraphy: detection of abnormal gallbladder motor function in patients with chronic acalculous gallbladder disease. J Nucl Med 32 (1991) 1695-1699
44. Ziessman H.A. Functional hepatobiliary disease: Chronic acalculous gallbladder and chronic acalculous biliary disease. Semin Nucl Med 36 (2006) 119-132
45. Yap L., Wycherley A.G., Morphett A.D., et al. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy. Gastroenterology 101 (1991) 786-793
46. DiBaise J.K., and Oleynikov D. Does gallbladder ejection fraction predict outcome after cholecystectomy for suspected chronic acalculous gallbladder dysfunction?. A systematic Review. Am J Gastroenterol 98 (2003) 2605-2611
47. Delgado-Aros S., Cremonini F., Bredenoord A.J., et al. Systematic review and meta-analysis: Does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain. Aliment Pharmacol Ther 18 (2003) 167-174
48. Hopman W.P., Jansen J.B., Rosebusch G., et al. Gallbladder contraction induced by cholecystokinin: bolus injection or infusion. BMJ 292 (1986) 375-376
49. Ziessman H.A., Fahey F.H., and Hixson D.J. Calculation of a gallbladder ejection fraction: Advantage of continuous sincalide infusion over the three-minute infusion method. J Nucl Med 33 (1992) 537-541
50. Ziessman H.A., Muenz L.R., Agarwal A.K., et al. Normal values for sincalide cholescintigraphy: Comparison of two methods. Radiology 221 (2001) 404-410
51. Raymond F., Lepanto L., Rosenthal L., et al. Tc-99m-IDA gallbladder kinetics and response to CCK in chronic cholecystitis. Eur J Nucl Med 14 (1988) 378-381
52. Sostre S., Canto M.I., and Kaloo A.N. Gallbladder response to a second dose of cholecystokinin during the same imaging study. Eur J Nucl Med 19 (1992) 964-965
53. Mackie C.R., Baxter J.N., Grime J.S., et al. Gallbladder empting in normal subjects: A data base for clinical cholescintigraphy. Gut 28 (1987) 137-141
54. Xynos E., Pechlivanides G., and Zoras O.J. Reproducibility of gallbladder emptying scintigraphic studies. J Nucl Med 35 (1994) 835-839
55. Bartel T.B., Juweid M.E., Ponto J.A., et al. Corn oil emulsion: a simple cholecystagogue for diagnosis of chronic acalculous cholecystitis. J Nucl Med 46 (2005) 67-74
56. Ziessman H.A., Jones D.A., Muenz L.R., et al. Cholecystokinin cholescintigraphy: Methodology and normal values using a lactose-free fatty-meal food supplement. J Nucl Med 44 (2003) 1263-1266
57. Catnach S.M., Fairclough P.D., Trembath R.C., et al. Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones. Gastroenterology 102 (1992) 2076-2081
58. Zeman R.K., Lee C., Jaffe M.H., et al. Hepatobiliary scintigraphy and sonography in early biliary obstruction. Radiology 153 (1984) 793-794
59. Kaplun L., Weissmann H.S., Rosenblatt R.R., et al. The early diagnosis of common bile duct obstruction using cholescintigraphy. JAMA 254 17 (1985) 2431-2434
60. Patch G.G., Morton K.A., Arias J.M., et al. Naloxone reverses pattern of obstruction of the distal common bile duct induced by analgesic narcotics in hepatobiliary imaging. J Nucl Med 32 (1991) 1270-1272
61. Corazziari E., Cicala M., Scopinaro F., et al. Scintigraphic assessment of SO dysfunction. Gut 52 (2003) 1655-1656
62. Sostre S., Kaloo A.N., Spiegler E.J., et al. A noninvasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: The scintigraphic score. J Nucl Med 33 (1992) 1216-1222
63. Craig A.G., Peter D., Saccone G.T., Ziesing P., et al. Scintigraphy versus manometry in patients with suspected biliary sphincter of Oddi dysfunction. Gut 52 (2003) 352-357
64. Thomas P.D., Turner J.G., Dobbs B.R., et al. Use of (99m)Tc-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure. Gut 46 (2000) 838-841
65. LoGuidice J.A., Geenen J.E., Hogan W., et al. Efficacy of the morphine-prostigmin test for evaluating patients with suspected papillary stenosis. Dig Dis Sci 24 (1979) 450-455
66. Madacsy L., Velosy B., Lonovics J., et al. Differentiation between organic stenosis and functional dyskinesia of the sphincter of Oddi with amyl nitrite-augmented quantitative hepatobiliary scintigraphy. Eur J Nucl Med 21 (1994) 203-208
67. Bertalan V., Madacsy L., Lavics L., et al. Scintigraphic sign of functional biliary obstruction is pathognomic for sphincter of Oddi dysfunction. Hepatogastroenterology 51 (2004) 76-81
68. Latshaw R.F., Kadir S., Witt W.S., et al. Glucagon-induced choledochal sphincter relaxation: Aid for expulsion of impacted calculi into the duodenum. AJR Am J Roentgenol 137 (1981) 614-616
69. Fullarton G.M., Falconer S., Campbell A., et al. Controlled study of the effect of nicardipine and ceruletide on the sphincter of Oddi. Gut 33 (1992) 550-553
70. Worobetz L.J., Baker R.J., McCallum J.A., et al. Effect of naloxone, morphine, and an enkephalin analogue on cholecystokinin octapeptide-stimulated gallbladder emptying. Am J Gastroenterol 77 (1982) 509-511
71. Tierney S., Quian Z., Burrow C., et al. Estrogen inhibits sphincter of Oddi motility. J Surg Res 57 (1994) 69-73
72. 99mTc-IDA scintigraphy in the evaluation of neonatal jaundice. Semin Nucl Med 11 (1981) 194-204
73. Gerhold J.P., Klingensmith W.C., Kuni C.C., et al. Diagnosis of biliary atresia with radionuclide hepatobiliary imaging. Radiology 146 (1983) 499-504
74. Poddar U., Bhattacharya A., Thapa B.R., et al. Ursodeoxycholic acid-augmented hepatobiliary scintigraphy in the evaluation of neonatal jaundice. J Nucl Med 45 (2004) 1488-1492
75. Gilmour S.M., Hershkop M., Reifen R., et al. Outcome of hepatobiliary scanning in neonatal hepatitis syndrome. J Nucl Med 38 (1997) 1279-1282